Gardasil News and Research

RSS

Gardasil is a vaccine that prevents the types of genital human papillomavirus (HPV) that cause most cases of cervical cancer and genital warts. The vaccine, Gardasil, is given in three shots over six-months. The vaccine is routinely recommended for 11 and 12 year old girls. It is also recommended for girls and women age 13 through 26 who have not yet been vaccinated or completed the vaccine series.

CDC says Gardasil's side effects minor

CDC officials on Thursday plan to present data at a meeting in Atlanta showing that 542 adverse health complaints have been reported about Merck's human papillomavirus vaccine Gardasil, but agency officials said the side effects of the vaccine are minor and that the vaccine does not require additional warning labels, the AP/Long Island Newsday reports .

25 Feb 2007

Some health experts concerned proponents of mandatory HPV vaccination are acting too soon

Some public health experts recently have expressed concern that proponents of human papillomavirus vaccination legislation -- including Merck, producer of the HPV vaccine Gardasil -- have acted "far too fast" and are "potentially undermining eventual prospects for the broadest possible immunization," the New York Times reports .

22 Feb 2007

Merck pledges to stop lobbying States on Gardasil

Merck has decided to suspend its campaign to lobby for state proposals that would mandate girls receive its human papillomavirus vaccine Gardasil in light of opposition from some parents, patient advocacy groups and public health officials, the Wall Street Journal reports.

22 Feb 2007

Gardasil reaction report released

The National Vaccine Information Center (NVIC) today released a new analysis of the federal Vaccine Adverse Event Reporting System (VAERS) reports of serious health problems following HPV vaccination (Merck's Gardasil) during the last six months of 2006.

21 Feb 2007

Texas lawmakers ask Gov. Perry to rescind order mandating HPV vaccination for girls entering sixth grade

Thirty-two Texas lawmakers last Thursday sent a letter to Gov. Rick Perry (R) reiterating their plea for him to rescind an executive order that would mandate vaccination against human papillomavirus for girls entering the sixth grade, the AP/Dallas Morning News reports.

13 Feb 2007

Actions taken on HPV vaccine proposals in Alabama, Louisiana, Utah, Washington

The following highlights recent news of state actions on human papillomavirus vaccine proposals. Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

13 Feb 2007

Merck lobbying States to mandate Gardasil for school girls

Merck recently has been providing lobbyists throughout the country with information about its human papillomavirus vaccine Gardasil in an effort to encourage states to mandate that middle-school age girls receive it, the Baltimore Sun reports.

30 Jan 2007

Voluntary HPV vaccination programs can work with 'informed and sensitive health education'

There is "no reason" why a voluntary human papillomavirus vaccination program that is "based on an informed and sensitive health education campaign ... would not work," Washington Post columnist Courtland Milloy writes in an opinion piece.

28 Jan 2007

Texas Legislature to consider requiring Gardasil for sixth grade girls

The Texas Legislature in the new session that begins on Tuesday will consider two bills (SB 110, HB 215) that would require girls entering the sixth grade to receive Merck's human papillomavirus vaccine Gardasil, KENS 5 Eyewitness News/San Antonio Express-News reports.

9 Jan 2007

Physician groups, CDC recommend HPV vaccination for girls ages 11, 12

Changes to the 2007 immunization schedules for children and adolescents in the U.S. -- issued by the American Academy of Pediatrics on Tuesday and approved by CDC and the American Academy of Family Physicians -- include recommending that girls ages 11 and 12 receive Merck's human papillomavirus vaccine Gardasil, Reuters Health reports .

7 Jan 2007

Australia to provide Gardasil at no cost to girls and women ages 12 to 26

Australian Prime Minister John Howard on Wednesday announced that the government will provide about $342 million for a program that will offer Merck's human papillomavirus vaccine Gardasil at no cost to girls and women ages 12 to 26 living in the country, Bloomberg reports.

2 Dec 2006

New Hampshire to provide Gardasil at no cost to girls

New Hampshire Department of Health and Human Services officials on Wednesday announced plans to become the first state to provide Merck's human papillomavirus vaccine Gardasil at no cost to girls ages 11 to 18 as part of a state program that offers immunizations to minors, the AP/Nashua Telegraph reports.

2 Dec 2006

40% of U.S. women ages 18 to 75 know about human papillomavirus

Forty percent of U.S. women ages 18 to 75 have heard about human papillomavirus and of those women, 20% are aware that it can cause cervical cancer, according to the National Cancer Institute's 2005 Health Information National Trends Survey, which was presented on Sunday at the American Association for Cancer Research's Frontiers in Cancer Prevention Research Meeting in Boston, Reuters Health reports.

14 Nov 2006

Cervical cancer vaccine to be included in school vaccination program in the U.S.

The U.S. government has added a new vaccine which protects girls and women from from cervical cancer to their subsidized vaccine program for schoolchildren.

2 Nov 2006

Sanofi Pasteur begins selling Gardasil in six E.U. countries

Sanofi Pasteur, a joint company of Merck and Sanofi-Aventis, recently began selling Merck's human papillomavirus vaccine Gardasil in Austria, Finland, Germany, Ireland, Sweden and the United Kingdom, Reuters reports (Reuters, 10/17).

19 Oct 2006

Michigan Senate approves bills that would require girls to receive HPV vaccine before entering sixth grade

The Michigan Senate on Wednesday voted 36-1 to approve two bills (SB 1416, SB 1417) that would require girls in the state entering the sixth grade in the 2007-2008 school year and beyond to have received Merck's human papillomavirus vaccine Gardasil, the AP/Detroit Free Press reports (AP/Detroit Free Press, 9/20).

26 Sep 2006

HPV vaccine Gardasil approved for sale in EU

The European Commission on Friday approved Merck's human papillomavirus vaccine Gardasil for sale and marketing in the European Union, London's Guardian reports (Batty, Guardian, 9/22).

26 Sep 2006

Michigan Bills introduced that would require girls to receive HPV vaccine before sixth grade

Michigan Sen. Beverly Hammerstrom (R) last Tuesday introduced two bills (SB 1416, SB 1417) that would require girls in the state entering the sixth grade in the 2007-2008 school year and beyond to have received Merck's human papillomavirus vaccine Gardasil, the Detroit News reports.

18 Sep 2006

Cervical cancer vaccines offer broader cancer protection

Researchers now believe the first ever cervical cancer vaccine may provide even more protection against the killer disease than first thought.

4 Sep 2006

Some parents have difficulties gaining access to insurance coverage for HPV vaccine Gardasil

Some parents seeking to vaccinate their daughters with Merck's human papillomavirus vaccine Gardasil have experienced difficulty in obtaining it or getting it covered by health insurance, the AP/Seattle Post-Intelligencer reports (Tanner, AP/Seattle Post-Intelligencer, 8/29).

1 Sep 2006